肺栓塞:从诊断到预后
本文综述肺栓塞诊断与风险分层的挑战,指出低风险患者可安全门诊抗凝,高风险(血流动力学不稳定)患者短期死亡率高,需紧急再灌注治疗及重症支持;中间风险尤其是中高危患者识别恶化是当代管理难点,需更精准理解预测临床恶化或死亡的患者及栓塞相关因素。
要点
- 低风险肺栓塞患者可安全门诊标准抗凝管理。
- 高风险肺栓塞定义为血流动力学不稳定,短期死亡率高,需考虑紧急药物或机械再灌注治疗,并给予重症监护支持、血管升压药及必要的心肺复苏。
- 中间风险(尤其中高危)患者虽血压正常但存在显著心肺应激,识别其恶化是当代急性肺栓塞管理的主要挑战。
核心结论
- 低风险肺栓塞患者可安全门诊抗凝;高风险患者短期死亡率高需紧急再灌注及重症支持;中间风险尤其中高危患者识别恶化是当代管理主要挑战。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 低风险肺栓塞患者可安全门诊标准抗凝管理。
- 高风险肺栓塞定义为血流动力学不稳定,短期死亡率高,需考虑紧急药物或机械再灌注治疗,并给予重症监护支持、血管升压药及必要的心肺复苏。
- 中间风险患者血压正常但存在显著心肺应激,仍可能临床恶化;识别中高危患者恶化是当代急性肺栓塞管理的主要挑战。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary embolism (PE) remains challenging to diagnose and, in particular, to risk stratify. Many patients with low-risk PE can be managed safely as outpatients with standard anticoagulation. At the other end of the risk spectrum, patients who present with haemodynamic instability, defined as high-risk PE, have a high short-term mortality and require consideration of urgent reperfusion therapy through pharmacologic or mechanical means, alongside critical care support, vasopressors and, when necessary, cardiopulmonary resuscitation. Perhaps the greatest challenge, however, lies between these two extremes with patients who remain normotensive despite evidence of significant cardiopulmonary stress and may still be at risk for clinical deterioration. Identifying which of these intermediate-risk, and particularly intermediate-high-risk, patients will deteriorate is a major challenge in the contemporary management of acute PE. 1 2 Developing a more precise understanding of which patient and PE-related factors predict clinical deterioration or death is therefore of significant...
引用
- Thorax:Pulmonary embolism: from diagnosis to prognosis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。